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Background: Vitamin K-dependent (VKD) proteins, including the mineralization inhibitor matrix-gla
protein (MGP), are found in joint tissues including cartilage and bone. Previous studies suggest low
vitamin K status is associated with higher osteoarthritis (OA) prevalence and incidence.
Objective: To clarify what joint tissues vitamin K is relevant to in OA, we investigated the cross-sectional
and longitudinal association between vitamin K status and knee OA structural features measured using
magnetic resonance imaging (MRI).
Methods: Plasma phylloquinone (PK, vitamin K1) and dephosphorylated-uncarboxylated MGP ((dp)
ucMGP) were measured in 791 older community-dwelling adults who had bilateral knee MRIs
(mean ± SD age ¼ 74 ± 3 y; 67% female). The adjusted odds ratios (and 95% conﬁdence intervals) [OR
(95%CI)] for presence and progression of knee OA features according to vitamin K status were calculated
using marginal models with generalized estimating equations (GEEs), adjusted for age, sex, body mass
index (BMI), triglycerides and other pertinent confounders.
Results: Longitudinally, participants with very low plasma PK (<0.2 nM) were more likely to have
articular cartilage and meniscus damage progression after 3 years [OR (95% CIs): 1.7(1.0e3.0), 2.6(1.3
e5.2) respectively] compared to sufﬁcient PK (1.0 nM). Higher plasma (dp)ucMGP (reﬂective of lower
vitamin K status) was associated with higher odds of meniscus damage, osteophytes, bone marrow le-
sions, and subarticular cysts cross-sectionally [ORs (95% CIs) comparing highest to lowest quartile: 1.6(1.1
e2.3); 1.7(1.1e2.5); 1.9(1.3e2.8); 1.5(1.0e2.1), respectively].
Conclusion: Community-dwelling men and women with very low plasma PK were more likely to have
progression of articular cartilage and meniscus damage. Plasma (dp)ucMGP was associated with pres-
ence of knee OA features but not progression. Future studies are needed to clarify mechanisms under-
lying vitamin Ks role in OA.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.o: M.K. Shea, USDA Human
y, Boston MA, USA.
ternational. Published by Elsevier LOsteoarthritis (OA) is a debilitating joint-disease characterized
by pathological changes in all joint tissues, including cartilage,
bone, meniscus (in the knee), and synovium, causing joint pain andtd. All rights reserved.
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been implicated in OA2,3. Because there is no known therapy to
slow OA progression, the identiﬁcation of simple and effective
strategies that may reduce OA progression is important to delay
disability and reduce the associated cost-burden.
Vitamin K is a fat-soluble nutrient that appears to have a role in
OA. In epidemiological studies, low circulating vitamin K was asso-
ciated with greater prevalence of hand and knee OA cross-section-
ally4 and with greater knee OA progression and cartilage loss
longitudinally5. The main function of vitamin K is as an enzymatic
cofactor for thegamma(g)-carboxylationof certain calcium-binding
proteins, including matrix-gla protein (MGP), a vitamin K-depen-
dent (VKD) mineralization inhibitor expressed in human articular
cartilage6. Once carboxylated, MGP inhibits ectopic mineralization
by binding calcium crystals, thereby inhibiting calcium crystal
growth, and by binding to and inhibiting bone morphogenic
protein-2, a protein that induces bone formation7e9. In human OA
cartilage, MGP is primarily uncarboxylated (ucMGP, the less func-
tional form), whereas in healthy articular cartilageMGP is primarily
carboxylated (functional)10, suggesting the carboxylation of MGP is
relevant to OA. MGP is also detectable in circulation and
desphospho-ucMGP [(dp)ucMGP] concentrations increase when
vitamin K status is low11, suggesting circulating (dp)ucMGP may
serve as a functional biomarker of VK status for tissues that useMGP.
In addition to MGP, other VKD proteins, including growth-arrest
speciﬁc gene 6, transforming growth factor b-induced protein ig-
h3, periostin, Gla-rich protein and osteocalcin are present in
cartilage and bone12e15so vitamin K may have multiple roles in
joint health. To clarify what joint tissues VK is relevant to in OA, we
investigated the cross-sectional and longitudinal associations be-
tween plasma vitamin K, (dp)ucMGP and structural features of knee
OA measured using MRI in older community-dwelling adults. We
hypothesized that lower plasma vitamin K and higher (dp)ucMGP
(reﬂective of lower vitamin K status) would be associated with
higher prevalence and progression of knee OA features reported to
be characterized by calcium depositione namely articular cartilage
and meniscus.
Methods
Participants were drawn from the Healthy, Aging, and Body
Composition study (Health ABC), an ongoing prospective longitu-
dinal cohort study designed to examine age-related changes in
physical function and body composition in older black and white
men and women. Between 1997 and 1998, 3075 well-functioning
older black and white adults (40% black, 50% female, aged 70e79)
were recruited from ﬁeld centers in Pittsburgh, PA and Memphis,
TN. At the time of recruitment, all participants were free of
disability in activities of daily living and reported no difﬁculty
walking ¼ mile or up 10 steps16. The knee OA sub-study was
initiated at the year 2 clinic visit (1998e99) when 640 participants
with qualifying knee pain and 505 randomly selected controls
underwent bilateral knee magnetic resonance imaging (MRIs).
Cases with qualifying knee pain were identiﬁed if they had “knee
pain, aching, or stiffness on most days for at least 1 month” at some
point over the previous year or if they reported moderate or worse
knee pain during the previous month in association with at least
one activity on the Western Ontario and McMaster Universities
Arthritis Index (WOMAC) knee pain scale17. Follow-up MRIs were
completed at the year 5 clinic visit (median follow-up¼ 37months)
on 581 participants. Because warfarin is a vitamin K antagonist,
participants in the knee OA sub-study who reported taking
warfarin at the year 2 or year 5 clinic visits were excluded (n ¼ 65).
All participants provided written informed consent and the insti-
tutional review boards at both study sites approved all protocols.Knee image acquisition and reading
Bilateral knee MRIs were obtained using a Sigma 1.5T MRI sys-
tem with a standard unilateral, commercial circumferential knee
coil at the year 2 clinic visit and again 3 years later, as described18.
Coronal, sagittal, and axial images were obtained. Coronal views
were T2-weighted fast spin-echo (FSE) (TR 3500 msec, TE 20/
60 msec) with a slice thickness of 4 mm, a 0.5-mm interslice gap,
two excitation, FOV 14 cm, and amatrix of 256 256 pixels. Sagittal
views were T2-weighted FSE, including the entire synovial cavity
with frequency-selective fat suppression (TR 4127 msec, TE 20/
60 msec), a 0.5-mm interslice gap, two excitation, and the same
FOV and matrix. Axial views were T2-weighted FSE (TR 2500 msec,
TE 20/60 msec) with a 1-mm interslice gap, one excitation, FOV
12 cm, and amatrix of 256 256 pixels). All follow-up images were
read as a pair with their corresponding baseline image in sequence
and have been evaluated semi-quantitatively using the Whole Or-
gan MRI Score (WORMS)19 by trained evaluators who were blinded
to participant clinical history, at the University of California San
Francisco's Arthritis Research Group. The inter-rater agreement for
WORMS assessment by the three Health ABCMRI readers was good
to excellent (intraclass correlation coefﬁcient (ICC) ¼ 0.63e0.93;
with ICC < 0.40 indicating poor agreement, 0.41e0.75 indicating
fair to good agreement, and ICC >0.75 indicating excellent
agreement)20.
Thresholds used to deﬁne abnormal MRI knee OA features are
summarized in Supplemental Table 1 21. Articular cartilage lesion
severity was scored on a 0e6 scale. Grade 1 lesions (signal abnor-
mality) do not reﬂect morphologic change, so they were grouped
with grade 0 for analysis. Osteophyte sizewas scored on a 0e7 scale.
Grade1 osteophytes are considered equivocal, sowere groupedwith
grade 0. Bone marrow lesions and subchondral cysts were each
scored on a 0e3 scale for size, and subchondral bone attrition was
scored on a 0e3 scale for severity. Synovitis/effusion was scored as
grade 0 (normal), grade 1 (<33% of the maximum potential disten-
sion), grade 2 (33e66%), or grade 3 (66%)Meniscus damage was
scored as grade 0 (intact), grade 1 (minor radial or parrot beak tear),
grade 2 (nondisplaced tear or prior surgical repair), grade 3 (dis-
placed tear, partial maceration, or partial resection), or grade 4
(complete maceration and destruction or complete resection)19. At
baseline each subregion was categorized as normal (grade 0) vs
having an abnormality (lesion present) for each feature. Progression
of each feature was deﬁned as a score increase of at least one in any
subregion. For articular cartilage damage and osteophyte progres-
sion, increases from grade 0 to 1 were not considered progression
since grade 1 for those features indicates abnormal signal but not
necessarily morphological change.
Vitamin K status
Blood samples were taken at the Year 2 clinic visit (1998/99)
after an overnight fast and stored at 70C until time of analysis.
(dp)ucMGP was measured from the same plasma samples using a
sandwich ELISA, which uses two monoclonal antibodies directed
against the nonphosphorylated amino acid sequence 3e15 and the
noncarboxylated amino acid sequence 35e49 in human MGP. The
reported intra- and inter-assay variability for this assay were 5.6%
and 9.9%, respectively24. Plasma phylloquinone (PK, vitamin K1)
was measured from stored samples using reversed-phase HPLC
with post-column, solid phase chemical reduction of VK to its hy-
droquinone, followed by ﬂuorometric detection at the Vitamin K
Laboratory at the USDA Human Nutrition Research Center on Aging
(HNRCA) at Tufts University22. This laboratory currently partici-
pates in the international vitamin K external quality assurance
scheme, KEQAS23. The limit of detection for circulating PK with this
assay using this sample volume available was <0.2 nmol/L22.
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Body weight and height were measured using a standard
balance-beam scale and Harpenden stadiometer (Holtain Ltd.,
Crosswell, UK), and body mass index (BMI) was calculated as
weight (kg)/(height (m)2). Interleukin-6 (IL-6) was measured in
fasting serum in duplicate by ELISA (Quantikine HS; R & D Systems,
Inc., Minneapolis, MN). Dietary intake over the previous year was
estimated using an interviewer-administered 108-item Food Fre-
quency Questionnaire (FFQ) developed speciﬁcally for Health ABC.
The FFQ food list was derived using 24-h recall data obtained from
the National Health and Nutrition Examination Survey (NHANES) III
for non-Hispanic black and white adults aged 65 and older residing
in the Northeast or South. The Health ABC FFQ was analyzed for
micronutrient and macronutrient content using the Block Dietary
Data System25. Physical activity was based on the reported time
spent in walking for exercise or in other walking (e.g., for trans-
portation) over the previous week25. The season during which the
blood sample was obtained was included to account for seasonal
effects on vitamin K. At the baseline clinic visit, demographic and
lifestyle characteristics, including age, sex, race, education, smoking
status and medication use were ascertained using an interviewer-
administered questionnaire. Triglycerides were measured in fast-
ing serum on a commercially available analyzer (Vitros 950; John-
son & Johnson, Rochester, NY). Clinic site was either Pittsburgh PA
or Memphis TN.
Statistical analyses
Given the novelty of plasma (dp)ucMGP and the lack of estab-
lished normal ranges, categories were based on distribution quar-
tiles. Plasma PK was categorized as <0.2 nmol/L (below the
detectable limit), 0.2e<1.0 nmol/L or 1.0 nmol/L, because
1.0 nmol/L is the concentration that is generally achieved when
adequate intakes (90 mg/day for women, 120 mg/day for men) are
met26,27. In descriptive analyses, differences in demographic, life-
style and clinical characteristics were examined across categories of
PK and (dp)ucMGP using general linear models for continuous
outcomes or the Chi-square tests for categorical outcomes. UsingTable I
Baseline characteristics according to plasma (dp)ucMGP quartile of 791 Health ABC part
otherwise
(dp)ucMGP range Q1: n
ND-1
Age (yr)y 74 (
Female (n(%)) 135 (
Black (n(%))y 137 (
BMI (kg/m2) 27.2 (
Triglycerides (mg/dl)y 112 (
IL-6 (pmol/L)y 2.2 (
Phylloquinone (nmol/L)y 0.9 (
Vegetable intake (servings/day) 3 (
Physical activity (n(%)) min walking/week 0 96 (
1e150 79 (
>150 40 (
Smoker (n(%)) Current 22 (
Former 88 (
Statin use (n(%))y 31 (
Education (n(%))y <High school 73 (
High school graduate 64 (
College graduate 78 (
Season (n(%)) DeceFeb 41 (
MareMay 62 (
JuneAug 47 (
SepteNov 65 (
Site (n(%) Pittsburgh)y 90 (
Qualifying knee pain (n(%)) 150 (
* The difference between the 75th and 25th percentiles.
y P  0.05 based on general linear models for continuous outcomes or the Chi-squarethe knee as the unit of analysis, the odds ratios (and 95% conﬁdence
intervals) [OR (95% CI)] for having abnormal knee OA features
(based on thresholds deﬁned in Supplemental Table I) according to
categories of PK and (dp)ucMGPwere calculated using themarginal
model with generalized estimating equations (GEEs) to account for
between-knee correlation within subject. Covariates included age,
sex, BMI, race, smoking status, season of blood draw, education, and
clinic site. We also adjusted for triglycerides and statin use because
vitamin K is transported on triglyceride-rich lipoproteins28 and
may be affected by lipid lowering medications. Additionally,
vitamin K status can reﬂect generally healthy lifestyles29, so vege-
table intake (an indicator of a healthy diet) and physical activity
were included as covariates. Since vitamin K has been shown to
reduce production of pro-inﬂammatory cytokines30, and inﬂam-
mation has been implicated in OA1, we included IL-6 as a covariate
as well. Longitudinal models were additionally adjusted for follow-
up time. Knees with the highest possible score at baseline for each
feature were removed from longitudinal models to prevent a ceil-
ing effect. We checked for non-linear associations between vitamin
K status and each knee OA feature cross-sectionally and longitu-
dinally by entering quadratic terms of the continuous exposures
into each model (i.e., plasma PK2 or (dp)ucMGP2). We also exam-
ined for effect modiﬁcation by sex and race by entering product
terms (i.e., sex*PK category, sex*(dp)ucMGP quartile) into each
model. Quadratic and interaction termswere considered signiﬁcant
at P < 0.05. In sensitivity analyses we excluded participants without
knee pain from cross-sectional and longitudinal analyses and
excluded participants without prevalent features at baseline from
longitudinal analyses. All analyses were carried out using SAS v 9.3
(SAS Inc., Cary, NC).
Results
After all exclusions, seven hundred ninety one (791) Health ABC
knee OA study participants not taking warfarin had usable baseline
knee MRIs. Measures of vitamin K status and pertinent covariates
were analyzed cross-sectionally. Compared to participantsicipants aged 70e79 y. Presented as median (interquartile range*), unless indicated
¼ 215
81 pmol/L
Q2: n ¼ 193
182-407 pmol/L
Q3: n ¼ 192
408-646 pmol/L
Q4: n ¼ 191
647 pmol/L
5) 74 (4) 74 (5) 75 (4)
63) 118 (61) 118 (61) 122 (64)
64) 92 (48) 77 (40) 60 (31)
6.5) 26.7 (5.7) 27.3 (5.2) 27.9 (6.2)
74) 115 (56) 122 (64) 133 (77)
2.1) 2.1 (2.2) 2.5 (2.2) 2.8 (2.9)
1.1) 0.8 (0.8) 0.8 (0.8) 0.7 (0.7)
2) 2 (2) 3 (2) 3 (2)
45) 82 (42) 79 (41) 84 (44)
37) 59 (31) 55 (29) 58 (30)
19) 52 (27) 58 (30) 49 (27)
10) 19 (10) 21 (11) 9 (5)
41) 80 (41) 44 (85) 85 (45)
7) 56 (15) 44 (12) 44 (12)
34) 42 (22) 46 (24) 35 (18)
30) 60 (31) 64 (33) 82 (43)
36) 91 (47) 82 (43) 74 (39)
19) 51 (26) 44 (23) 48 (25)
29) 51 (26) 59 (31) 55 (29)
22) 38 (20) 34 (18) 36 (19)
30) 53 (27) 55 (29) 52 (27)
42) 95 (49) 113 (59) 111 (58)
70) 140 (73) 131 (68) 137 (72)
tests for categorical outcomes.
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had a lower BMI (27.7 ± 4.8 compared to 28.5 ± 5.5 kg/m2,
P ¼ 0.02), were more likely to be female (62% compared to 53%,
P ¼ 0.01) and have graduated college (41% compared to 34%,
P < 0.01). Relatively more participants who reported knee pain
were in the group excluded due to missing data as well (29%
compared to 18%, P ¼ 0.01). Of the 791 participants with complete
MRI and covariate data at baseline, 523 also had follow-up MRIs so
were also analyzed longitudinally. Participants missing follow-up
MRIs were more likely to be male (59% compared to 47%,
P < 0.01), to be current smokers (11% compared to 8%, P ¼ 0.03), to
not have completed education beyond high school (63% compared
to 58%, P ¼ 0.01) and had higher IL6 levels (median 2.5 pg/ml vs
2.3 pg/ml, P ¼ 0.02). The prevalence of qualifying knee pain was
similar between the two groups (72% compared to 75%, P ¼ 0.12)
and they did not differ in any other pertinent characteristics.
Baseline characteristics according to (dp)ucMGP quartile are
shown in Table I. Plasma (dp)ucMGP was positively correlated with
triglycerides and IL-6. Participants with lower (dp)ucMGP were
more likely to be black, from the Memphis study site, not take
statins and not have graduated high school (Table I). Plasma PK was
inversely correlated with plasma (dp)ucMGP. As expected, PK was
positively correlated with triglycerides because vitamin K is
transported on triglyceride-rich lipoproteins (Table II). Participants
with lower baseline PK were more likely to be male, be from the
Pittsburgh study site and smoke. Green leafy vegetables are the
primary dietary source of PK so, as expected, PK was positively
correlated with vegetable intake.
Cross-sectional results
The ORs (and 95% CIs) for having knee OA features assessed
using MRI at baseline according to plasma (dp)ucMGP and PK
categories are shown in Fig. 1. Participants in the higher quartiles of
plasma (dp)ucMGP (reﬂective of lower vitamin K status) weremore
likely to have osteophytes, bone marrow lesions, subarticular cysts,
and meniscal damage at baseline (Fig. 1. The associations betweenTable II
Baseline characteristics according to plasma phylloquinone category of 791 Health ABC pa
otherwise
<0.2 nm
Age (yr) 75 (4)
Female (n(%))y 37 (54
Black (n(%)) 30 (44
BMI (kg/m2) 27.0 (7.4
Triglycerides (mg/dl)y 102 (45
IL-6 (pmol/L)y 2.8 (2.9
(dp)ucMGP (pmol/L)y 311 (49
Vegetable intake (servings/day) 2 (2)
Physical activity (min walking/week) 0 29 (43
1e150 26 (38
>150 13 (19
Smoker (n(%))y Current 10 (5)
Former 33 (49
Statin use (n(%)) 14 (10
Education (n(%)) <High school 21 (31
High school graduate 19 (28
College graduate 28 (41
Season (n(%))y DeceFeb 9 (13
MareMay 5 (7)
JuneAug 19 (27
SepteNov 35 (51
Site (n(%) Pittsburgh)y 44 (65
Qualifying knee pain (n(%)) 49 (72
* The difference between the 75th and 25th percentiles.
y P  0.05 based on general linear models for continuous outcomes or the Chi-square
z The lower detectable limit for this assay.plasma (dp)ucMGP and bone marrow lesions, subarticular cysts,
and meniscal damage appear to be nonlinear (plasma (dp)
ucMGP2terms P < 0.01, P ¼ 0.05, and P ¼ 0.04 respectively; Fig. 1).
These cross-sectional ﬁndings were not appreciably different when
analyses were restricted to participants with qualifying knee pain
(n ¼ 558). None of the cross-sectional associations between plasma
(dp)ucMGP and knee OA features on MRI differed by sex (all sex P-
for-interaction > 0.29). However, we detected an interaction be-
tween plasma (dp)ucMGP and race with respect to articular carti-
lage damage (P-for-interaction ¼ 0.02), such that blacks in the
higher (dp)ucMGP quartiles were more likely to have articular
cartilage damage at baseline [OR (95% CI), compared to Q1:
Q2 ¼ 1.3(0.8e2.3); Q3 ¼ 2.4(1.2e5.1); Q4 ¼ 2.3(1.1e5.0)]. Among
whites, (dp)ucMGP was not associated with articular cartilage
damage at baseline [OR (95% CI),compared to Q1:
Q2 ¼ 0.7(0.4e1.3); Q3 ¼ 0.9(0.5e1.6); Q4 ¼ 0.8(0.5e1.4)].
Except for higher odds of prevalent subarticular cysts among
those with non-detectable plasma PK, PK was not signiﬁcantly
associated with presence of abnormal knee OA features at baseline.
The associations between PK and knee OA features on MRI did not
have a quadratic component (all plasma PK2 P > 0.30). None of the
cross-sectional associations between PK and knee OA differed by
sex (all sex P-for-interaction > 0.09). We detected interaction be-
tween PK and race with respect to meniscal damage (P-for-
interaction ¼ 0.01), such that whites with non-detectable plasma
PK were more likely to have meniscal damage at baseline [OR (95%
CI), compared to 1.0 nmol/L: non-detectable ¼ 2.6(1.3e5.9);
detectable to <1.0 nmol/L ¼ 1.0(0.7e1.5)]. PK was not associated
with meniscal damage among blacks at baseline [OR (95% CI),
compared to 1.0 nmol/L: non-detectable ¼ 0.7(0.3e1.5); detect-
able to <1.0 nmol/L ¼ 0.9(0.6e1.4)].
Longitudinal results
Participants with non-detectable plasma PK at baseline were
more likely to have worsening of articular cartilage damage and
meniscal damage at 3 years of follow-up, (Fig. 2). Compared to therticipants aged 70e79 y. Presented as median (interquartile range*), unless indicated
ol/Lz (n ¼ 68) 0.2e1.0 nmol/L (n ¼ 403) 1.0 nmol/L (n ¼ 320)
75 (5) 74 (4)
) 240 (60) 216 (68)
) 186 (46) 150 (47)
) 27.3 (5.6) 27.7 (5.8)
) 116 (58) 131 (90)
) 2.4 (2.3) 2.4 (2.3)
4) 429 (481) 344 (483)
2 (2) 3 (2)
) 176 (44) 136 (44)
) 123 (31) 102 (32)
) 104 (26) 82 (26)
41 (10) 20 (6)
) 176 (46) 129 (38)
) 86 (11) 75 (12)
) 97 (24) 78 (24)
) 142 (43) 109 (40)
) 164 (41) 133 (42)
) 109 (27) 66 (21)
116 (29) 106 (33)
) 61 (15) 75 (48)
) 117 (28) 73 (20)
) 284 (60) 138 (47)
) 284 (70) 225 (70)
tests for categorical outcomes.
Fig. 1. Adjusted ORs with 95% CIs* for prevalent knee OA features detected on MRI according to plasma (dp)ucMGP quartile (top) and phylloquinone category (bottom) and in 791
Health ABC participants * adjusted for age, sex, BMI, race, smoking, vegetable intake, physical activity (time spent walking/week), triglycerides, statin use, IL-6, season of blood draw,
education, and study site.
M.K. Shea et al. / Osteoarthritis and Cartilage 23 (2015) 370e378374lowest (dp)ucMGP quartile, participants in quartile 2 were more
likely to have bone attrition progression. Otherwise knee OA pro-
gression did not appear to differ according to plasma (dp)ucMGP
quartile (Fig. 2). When analyses were restricted to participants with
qualifying knee pain at baseline (n ¼ 558) the association between
PK and worsening of articular cartilage damage became stronger:
OR (95% CI) ¼ 2.0(1.1e3.7) among those with non-detectable PK.
Otherwise, the cross-sectional and longitudinal results were not
appreciably different in this sub-group. Results were also similar
when participants without prevalent knee OA features at baseline
were excluded. None of the associations between PK or (dp)ucMGPand knee OA feature progression had a quadratic component (all
PK2 P> 0.11; all plasma (dp)ucMGP2 P > 0.17). Associations between
PK and (dp)ucMGP and progression of knee OA features did not
differ by sex or race (all interaction term P-values  0.06).
Discussion
We hypothesized higher plasma (dp)ucMGP (reﬂective of lower
vitamin K status) would be associatedwithworse articular cartilage
and meniscal damage because those joint tissues are susceptible to
calcium deposition and mineralization31. Higher (dp)ucMGP was
Fig. 2. Adjusted ORswith 95% CIs* for worsening of knee OA features after 3 years detected on MRI according to plasma (dp)ucMGP quartile (top) and phylloquinone category
(bottom) in 523 Health ABC participants. * adjusted for age, sex, BMI, race, smoking, vegetable intake, physical activity (time spent walking/week), triglycerides, statin use, IL-6,
season of blood draw, education, study site and follow-up time.
M.K. Shea et al. / Osteoarthritis and Cartilage 23 (2015) 370e378 375associated with higher odds of meniscal damage cross-sectionally,
but it was not associated with articular cartilage damage. Partici-
pants with higher (dp)ucMGP were also more likely to have
osteophytes, bone marrow lesions, and subarticular cysts. Since OA
is a disease of the whole joint, and MGP is also found in bone10,
these ﬁndings may indicate a role for MGP in subarticular bone
turnover. However, our cross-sectional ﬁndings were not
conﬁrmed longitudinally ((dp)ucMGP was not associated with
progression of any feature over 3 years), so reverse causation may
be involved.Older community-dwelling adults with very low plasma PK
(deﬁned as below the assay limit of detection, <0.2 nmol/L) had a
1.7- and 2.6-fold higher odds of worsening cartilage damage and
meniscal damage over 3 years. Our data also suggest participants
with very low PK were more likely to have bone attrition, sub-
articular cyst, and osteophyte progression, but statistical signiﬁ-
cance was not reached [OR (95% CI)s: 1.9(0.9e3.6); 1.5(0.8e2.7);
1.5(0.8e2.8) respectively]. Because the circulating concentration of
PK considered sufﬁcient is not deﬁned, we chose thresholds based
on the assay limit of detection (<0.2 nmol/L) and the concentration
M.K. Shea et al. / Osteoarthritis and Cartilage 23 (2015) 370e378376generally achieved when recommended intakes are met (1.0 nmol/
L). In Health ABC, only very low circulating PK was associated with
worsening of any knee OA features. In the Multicenter Osteoar-
thritis Study (MOST), plasma PK < 0.5 nmol/L was associated with a
more than 1.5-fold higher risk for incident radiographic knee OA
and amore than 2-fold increased risk for incident articular cartilage
lesions over 30 months5. In the Framingham Offspring Study,
circulating PK < 1.0 nmol/L was associated with a higher prevalence
of hand and knee OA cross-sectionally4. However, we did not ﬁnd
plasma PK to be associated with presence of any feature cross-
sectionally. A similar inconsistency has been reported in other
studies of vitamin K status and chronic disease. For example, serum
PK was associated with progression but not prevalence of coronary
artery calcium (a condition in which a role for vitamin K is sug-
gested, based on similar mechanisms as OA) in community dwell-
ing adults32.
That very low plasma PK was associated with worsening artic-
ular cartilage and meniscal damage, but (dp)ucMGP was not asso-
ciated with progression of OA features may be because VKs role in
these pathologies is independent of its function as an enzymatic co-
factor. The role of vitamin K as an enzyme cofactor is post-
translational, hence one would predict that vitamin K determines
carboxylation of the VKDP, but not expression. However, vitamin K
was shown to regulate expression of articular cartilage matrix
genes (including MGP)33,34, so alternate roles for vitamin K in joint
health are plausible. Misra and colleagues found MGP poly-
morphisms, but not circulating concentrations, were associated
with hand OA in older adults35, suggesting gene expression to be
more relevant to OA than circulating MGP or its associated
carboxylation status. Alternately, VKD proteins other than MGP are
found in joint tissues12e15, so carboxylation of these proteins by
vitamin K may be more relevant to OA.
While associations between circulating vitamin K and carti-
lage damage/loss have been reported5, our ﬁnding that low
plasma PK was associated with meniscal damage is novel.
Meniscal injury resulting from trauma is a strong risk factor for
OA36. But, meniscal degeneration also occurs in the absence of
trauma, and becomes more prevalent with age37. Age-related
meniscal lesions are associated with knee OA, and are reported
to occur even before cartilage damage is apparent38,39. VKD
proteins have not been studied in the meniscus so mechanisms
underlying vitamin Ks association with meniscal degeneration
are uncertain. Since the meniscus is ﬁbro-cartilaginous tissue, it
would follow that the same VKD proteins found in articular
cartilage are also in the meniscus. However, the collagen content
and non-collagenous proteins in meniscus are different from
articular cartilage40, so it is plausible VKD proteins in the two
tissues likewise differ. As this has not been studied, our ﬁndings
are hypothesis-generating.
Our study is strengthened by the longitudinal design and
assessment of knee OA features using MRI, which provides a
more detailed and comprehensive assessment of structural
changes in the whole knee joint. To the best of our knowledge
this is also the ﬁrst assessment of vitamin K status and OA to use
both plasma PK and (dp)ucMGP as indicators of status. However,
the following limitations merit consideration. While circulating
(dp)ucMGP reﬂects VK status, it is also dependent on the total
amount of MGP in circulation such that the more total MGP
synthesized, the more MGP there is to be carboxylated. This is an
important distinction because both vitamin K status and total
MGP (measured regardless of its carboxylation status) were
independently identiﬁed as signiﬁcant predictors of circulating
(dp)ucMGP in older adults11. Since total MGP has not been
measured in Health ABC we were unable to adjust our models to
express (dp)ucMGP as a ratio of total MGP, such as is the practicewith other VKDP. Our hypothesis that vitamin K status would be
associated with outcomes prone to calciﬁcation because of MGPs
role as a mineralization inhibitor was supported by our ﬁndings
that very low PK was associated with higher odds of meniscal and
cartilage damage progression. However, calcium deposition was
not directly scored on the MRIs.
We adjusted for vegetable intake and physical activity (time
spent walking per week) to account for healthy lifestyles which can
reﬂect vitamin K status29, but residual confounding may persist.
Health ABC participants were selected because they reported being
well-functioning at 70e79 years old, and our ﬁndings may not be
generalizable to dissimilar groups. Meniscal degeneration was
likely more relevant to this cohort, given their age, which
strengthened our ability to detect associations. Our results did not
appear to differ in men and women, and the majority of our results
were consistent between blacks and whites. We detected race in-
teractions with respect to cartilage and meniscus damage cross-
sectionally. Since we did not hypothesize associations would
differ by race, type I error is a possible explanation. However, knee
OA41 and circulating PK42 are reported to differ by race and
ethnicity, and our data suggest (dp)ucMGP does likewise (Table II),
so these ﬁndings merit future investigation. There were some dif-
ferences between participants who had follow-up MRIs and those
missing follow-up MRIs, so the generalizability of our longitudinal
ﬁndings may be limited. It is plausible those who did not
return had more severe knee OA, so attrition bias merits
consideration.
Consistent with the only other known longitudinal study of
vitamin K and OA progression, (which found low plasma PK was
associated with more cartilage loss5), our results suggest vitamin K
is implicated in progression of several distinct pathologies of OA
affected joint tissues. Since plasma (dp)ucMGP was associated with
knee OA features cross-sectionally but not longitudinally, future
studies are needed elucidate mechanisms underlying vitamin Ks
role in OA progression.
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